Essayer OR - Gratuit

US drug regulator faces Trump heat

Down To Earth

|

January 16, 2025

FAILED REPUBLICAN presidential candidate Vivek Ramaswamy is making more news now than during his doomed attempt to get the party nomination for president. Ramaswamy's decision to throw in the towel and back Donald Trump after his campaign went nowhere showed acumen, the kind he is famous for in the investment world.

US drug regulator faces Trump heat

The president-elect has appointed the Indianorigin pharma investor, along with Elon Musk, as the head of an initiative to slash the federal bureaucracy. For Ramaswamy, heading the Department of Government Efficiency (DOGE) is the perfect reward: he does not like federal agencies and wants to shut down the Department of Education and the Federal Bureau of Investigation, and drastically restructure the Federal Reserve. But his main target is the Food and Drug Administration (FDA), the federal pharmaceutical regulator which has been in his cross hairs since the time he set up his drug manufacturing company Roivant Sciences and its much hyped drug failed to make the cut.

The story of Ramaswamy and his visceral antipathy to FDA is tied up with his business approach to pharma manufacture. He is given to projecting himself as a scientist from the biotechnology sphere, although he is no scientist, and has just an undergraduate degree in biology.

His graduate degree is in law and he started his career with a hedge fund company where he specialised in biotech investments. That appears to have fuelled the idea of setting up his own pharma ventures. His model was simple: scour the patent web for drugs that had been abandoned by pharma majors, buy out the patents-these could be had for a song-and develop and bring them to market to make a killing. The model was very much that of Martin Shkreli's, which we wrote about five years ago (see 'Encouraging orphan drugs', Down To Earth, November 1-15, 2019).

Shkreli was also a hedge fund manager who co-founded drug companies Retrophin and Turing Pharmaceuticals and became notorious for his rapacious pricing of pyrimethamine, a drug to treat parasitic infections. Shkreli had bought the rights to the drug at a throwaway price and hiked its price by 5,000 per cent.

PLUS D'HISTOIRES DE Down To Earth

Down To Earth

Himalayan states reel even as monsoon ends

EVEN AS the 2025 southwest monsoon began withdrawing from western Rajasthan on September 14-three days ahead of its normal date and the earliest in the past 10 years-the Himalayan states continue to be battered by heavy rainfall and flooding.

time to read

1 min

October 01, 2025

Down To Earth

A generation in protest

ON SEPTEMBER 1, there were 30 anti-government protests globally, according to Carnegie's global protest tracker. In the 12 months prior to this, the world witnessed 159 anti-government protests in 71 countries. What defines these protests is an overwhelming participation from youth. “The proportion of people willing to participate in demonstrations has increased to its highest levels since the 1990s, and the number of protests has also risen in this period,” says a Unicef report. Massive protests have caused change in regimes in Nepal, Bangladesh and Sri Lanka.

time to read

2 mins

October 01, 2025

Down To Earth

Down To Earth

EU misses deadline to set new targets

EU'S CLIMATE ministers on September 18 confirmed that the bloc will miss a global deadline to set new emissions-cutting targets in time for a meeting of the UN General Assembly (UNGA) at the end of the month.

time to read

1 min

October 01, 2025

Down To Earth

Down To Earth

The catalyst within

HORMONES NOT ONLY SHAPE ONE'S HEALTH, BUT HAVE LIKELY IMPACTED GLOBAL EVENTS

time to read

4 mins

October 01, 2025

Down To Earth

Down To Earth

SIP AND UNWIND

Ashwagandha, one of the most revered herbs in ayurvedic medicine, has found its place in contemporary wellness recipes

time to read

3 mins

October 01, 2025

Down To Earth

Down To Earth

Delhi court ban on Sci-Hub is bad news

Researchers will be hit by the loss of the free science website while big publishers are milking India on subscriptions

time to read

4 mins

October 01, 2025

Down To Earth

Don't push limits

WE CANNOT develop the Himalayas as if they were the plains, or a colony in South Delhi. This must be the lesson from this year's season of despair. The world's youngest mountain range, made of moraine, mud and rock, has been battered by rain. It has literally come crashing down, bringing with it homes, schools, fields, roads, bridges and much of the expensive infrastructure built by governments. The cost of this destruction—besides the tragic and irreplaceable loss of human lives—will be massive. Years of public and private investment have been lost.

time to read

3 mins

October 01, 2025

Down To Earth

Down To Earth

'A separate Local Government Service Commission can be set up to recruit panchayat employees'

The 73rd Amendment to the Constitution of India calls upon states to enact laws that enable panchayats to function as local governments. To assess the extent of this devolution of power, the Union Ministry of Panchayati Raj has studied and ranked the states since 2004.

time to read

4 mins

October 01, 2025

Down To Earth

Down To Earth

GLOBAL SOUTH REIMAGINED

In an increasingly fractured world marked by unilateralism and weakened climate cooperation, civil society must elevate Global South cohesion as a top climate agenda

time to read

4 mins

October 01, 2025

Down To Earth

Down To Earth

A mandatory requirement

Assessment of a river's sand replenishment is now a legal requirement for obtaining environmental clearance to mine the resource

time to read

3 mins

October 01, 2025

Listen

Translate

Share

-
+

Change font size